Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/13568
Title: Analysis and forecasting incidence, intensive care unit admissions, and projected mortality attributable to covid-19 in Portugal, the UK, Germany, Italy, and France: Predictions for 4 weeks ahead
Authors: Carvalho K.
Vicente J.
Jakovljevic, Mihajlo
Teixeira, João
Issue Date: 2021
Abstract: The use of artificial neural networks (ANNs) is a great contribution to medical studies since the application of forecasting concepts allows for the analysis of future diseases propagation. In this context, this paper presents a study of the new coronavirus SARS-COV-2 with a focus on verifying the virus propagation associated with mitigation procedures and massive vaccination campaigns. There were two proposed methodologies in making predictions 28 days ahead for the number of new cases, deaths, and ICU patients of five European countries: Portugal, France, Italy, the United Kingdom, and Germany. A case study of the results of massive immunization in Israel was also considered. The data input of cases, deaths, and daily ICU patients was normalized to reduce discrepant numbers due to the countries’ size and the cumulative vaccination values by the percentage of population immunized (with at least one dose of the vaccine). As a comparative criterion, the calculation of the mean absolute error (MAE) of all predictions presents the best methodology, targeting other possibilities of use for the method proposed. The best architecture achieved a general MAE for the 1-to-28-day ahead forecast, which is lower than 30 cases, 0.6 deaths, and 2.5 ICU patients per million people.
URI: https://scidar.kg.ac.rs/handle/123456789/13568
Type: article
DOI: 10.3390/bioengineering8060084
SCOPUS: 2-s2.0-85110117838
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

127

Downloads(s)

8

Files in This Item:
File Description SizeFormat 
10.3390-bioengineering8060084.pdf9.51 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons